Frontlight ResearchEarly access
Trial site
Barrie
- 3running trials
The trials here
What the 3 trials at this site are about, from their registry records.
- Conditions
- Psoriasis2 trials
- Hidradenitis suppurativa1 trial
- Phase
- Phase 23 trials
- Status
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Recruiting1 trial
- Lead sponsor
- Oruka Therapeutics, Inc.3 trials
Running trials
Enrolling by invitation
Recruiting
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
Active, not recruiting
Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa1 recruiting
- Psoriasis1 recruiting
Site data: ClinicalTrials.govUpdated 13 Nov 2026